Loch R. Macdonald

CIK 1653008 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 30, 2015 · Latest: Sept. 30, 2015

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 16 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

16 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 22, 2018 PDSB S 10b5-1 2,500 $16.41 $41,025 570,602 Direct -0.44% Disposed -99.9% (price as of 2026-08-21)
March 21, 2018 PDSB S 10b5-1 2,500 $16.52 $41,300 573,102 Direct -0.43% Disposed -99.9% (price as of 2026-08-21)
March 20, 2018 PDSB S 10b5-1 5,000 $16.47 $82,350 575,602 Direct -0.86% Disposed -99.9% (price as of 2026-08-21)
March 19, 2018 PDSB S 10b5-1 2,500 $16.66 $41,650 580,602 Direct -0.43% Disposed -99.9% (price as of 2026-08-21)
Feb. 22, 2018 PDSB S 10b5-1 2,500 $14.49 $36,225 583,102 Direct -0.43% Disposed -99.9% (price as of 2026-08-21)
Feb. 21, 2018 PDSB S 10b5-1 5,000 $13.82 $69,100 585,602 Direct -0.85% Disposed -99.9% (price as of 2026-08-21)
Feb. 20, 2018 PDSB S 10b5-1 5,000 $13.75 $68,750 590,602 Direct -0.84% Disposed -99.9% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
April 14, 2025 GRCE Stock Option (Right to Buy) Common Stock (40,000) $2.08 April 14, 2035 40,000 Acquired
May 6, 2024 GRCE Stock Options (Right to Buy) Class A Common Shares (25,380) $2.96 May 6, 2034 25,380 Acquired
July 14, 2023 GRCE Stock Options (Right to Buy) Class A Common Shares (60,000) $2.64 July 14, 2033 60,000 Acquired
March 15, 2019 PDSB Restricted Stock Units Common Stock (10,000) — — 10,000 Disposed
Aug. 14, 2018 PDSB Restricted Stock Units Common Stock (10,000) — — 10,000 Acquired
June 19, 2018 PDSB Stock Option (Right To Purchase) Common Stock (20,000) $1.10 — 20,000 Acquired
March 13, 2017 PDSB Stock Option (right To Purchase) Common Stock (110,000) $8.86 March 13, 2027 110,000 Acquired
Jan. 23, 2017 PDSB Stock Option (right To Purchase) Common Stock (25,000) $2.04 Oct. 11, 2023 25,000 Disposed
Feb. 16, 2016 PDSB Stock Option (Right to Purchase) Common Stock (85,000) $6.99 Feb. 16, 2026 85,000 Acquired
Oct. 6, 2015 PDSB Series C-1 Convertible Preferred Stock Common Stock (3,928) — — 5,373 Disposed
Oct. 6, 2015 PDSB Series A Convertible Preferred Stock Common Stock (18,274) — — 25,000 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 7 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 30, 2015 PDSB Common Stock 548,205 Direct
Sept. 30, 2015 PDSB Series A Convertible Preferred Stock→ Common Stock — Direct
Sept. 30, 2015 PDSB Series C-1 Convertible Preferred Stock→ Common Stock — Direct
Sept. 30, 2015 PDSB Stock Option (right to purchase)→ Common Stock (100,504) 100,504 Direct
Sept. 30, 2015 PDSB Stock Option (right to purchase)→ Common Stock (63,957) 63,957 Direct
Sept. 30, 2015 PDSB Stock Option (right to purchase)→ Common Stock (116,950) 116,950 Direct
Sept. 30, 2015 PDSB Stock Option (right to purchase)→ Common Stock (219,282) 219,282 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PDSB

M.D., Ph.D. Chief Scientific Officer(3)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2018 $150,750 — — — — — $272,179 $443,017
2017 $402,000 — — $724,493 $153,765 — $10,800 $1,291,058
2016 $390,000 — — $409,005 $175,500 — — $974,505

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.